Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://xitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.5K
- Following4.7K
- Followers165K
- Likes45K
Pinned Tweet
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine.
Meet the 2026 #STATWunderkinds!
statnews.com/wunderkinds/
A type of targeted chemotherapy developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer. statnews.com/2026/10/26/merc…
A House lawmaker is investigating whether the three largest PMS targeted independent pharmacies withretaliatory audits. trib.al/W8NN2mi
A decade ago, GSK was out of oncology. It could soon pick up approval for its sixth cancer drug. trib.al/gp5RBEw
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer. statnews.com/2026/10/26/incy…
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer trib.al/IPzvUbi
New approach to women's heart health focuses on four stages of life statnews.com/2026/10/26/hear…
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel. trib.al/NUtFCZ4
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer trib.al/u8dMA6E
Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial trib.al/fH9OzZh
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's research and business strategies. statnews.com/2026/10/26/mode…
In an interview with STAT at #ESMO, Moderna CEO Stéphane Bancel said Moderna and Merck are racing to submit the vaccine for FDA approval, which he expects in 2027.
The companies, he said, are also preparing to test it aggressively in other cancers. trib.al/s6N9mYb
STAT retweeted
I spoke with Moderna $MRNA CEO Stéphane Bancel about intismeran and what's next for the cancer vaccine and the biotech he runs.
"We know the clinical impact in the Phase 3 study is real and big, so we need to go and be aggressive. We need to explore the biology. There will be some risk, because it’s not going to work everywhere."
Read the Q&A:
statnews.com/2026/10/26/mode… #ESMO26
For the first time, a human has been infected with the Shamonda virus, according to French officials. The World Health Organization says broader transmission is unlikely. trib.al/sJiQQss
“We shouldn't confuse illness and the hardships that come with living,” writes family nurse practitioner Kirsten Balin. trib.al/UpGms3U
“What we don’t know is whether people are disconnecting from one another, gradually, over months of interacting with chatbots,” researchers write. trib.al/rU5iKnd
New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health. trib.al/OG4a4MQ
The center will study the long-term impact of infections, in addition to RFK Jr.'s focus on vaccines. trib.al/J0aEERU
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy. trib.al/fn9nyhn
STAT reporters react to the 'emotional' scenes of Elizabeth Holmes in the ‘You Can See Everything’ documentary.
STAT retweeted
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
